Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury
- PMID: 25339176
- PMCID: PMC4271222
- DOI: 10.1074/jbc.M114.587840
Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury
Abstract
Increase in protein synthesis contributes to kidney hypertrophy and matrix protein accumulation in diabetes. We have previously shown that high glucose-induced matrix protein synthesis is associated with inactivation of glycogen synthase kinase 3β (GSK3β) in renal cells and in the kidneys of diabetic mice. We tested whether activation of GSK3β by sodium nitroprusside (SNP) mitigates kidney injury in diabetes. Studies in kidney-proximal tubular epithelial cells showed that SNP abrogated high glucose-induced laminin increment by stimulating GSK3β and inhibiting Akt, mTORC1, and events in mRNA translation regulated by mTORC1 and ERK. NONOate, an NO donor, also activated GSK3β, indicating that NO may mediate SNP stimulation of GSK3β. SNP administered for 3 weeks to mice with streptozotocin-induced type 1 diabetes ameliorated kidney hypertrophy, accumulation of matrix proteins, and albuminuria without changing blood glucose levels. Signaling studies showed that diabetes caused inactivation of GSK3β by activation of Src, Pyk2, Akt, and ERK; GSK3β inhibition activated mTORC1 and downstream events in mRNA translation in the kidney cortex. These reactions were abrogated by SNP. We conclude that activation of GSK3β by SNP ameliorates kidney injury induced by diabetes.
Keywords: Cell Signaling; Diabetic Nephropathy; Eukaryotic Translation Initiation; Extracellular Matrix Protein; Glycogen Synthase Kinase 3 (GSK-3); Kidney; Kidney Hypertrophy; Mammalian Target of Rapamycin (mTOR); Sodium Nitroprusside; Type 1 Diabetes.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures










References
-
- Covington M. D., Schnellmann R. G. (2012) Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury. Kidney Int. 81, 391–400 - PubMed
-
- Fox C. S., Matsushita K., Woodward M., Bilo H. J., Chalmers J., Heerspink H. J., Lee B. J., Perkins R. M., Rossing P., Sairenchi T., Tonelli M., Vassalotti J. A., Yamagishi K., Coresh J., de Jong P. E., Wen C. P., Nelson R. G. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380, 1662–1673 - PMC - PubMed
-
- Mason R. M., Wahab N. A. (2003) Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358–1373 - PubMed
-
- Mariappan M. M., Feliers D., Mummidi S., Choudhury G. G., Kasinath B. S. (2007) High glucose, high insulin, and their combination rapidly induce laminin-β1 synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes 56, 476–485 - PubMed
-
- Mariappan M. M., Shetty M., Sataranatarajan K., Choudhury G. G., Kasinath B. S. (2008) Glycogen synthase kinase 3β is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells. J. Biol. Chem. 283, 30566–30575 - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous